3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Advanced Solid Tumor
3
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Head and Neck Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Advanced Solid Tumour
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Gemcitabine
11
Magnetic Resonance Spectroscopy
10
Specimen Handling
8
Cisplatin
7
pembrolizumab
6
Radiation
5
Mitomycin
4
Fluorouracil
4
Cystoscopy
4
enfortumab vedotin
3
durvalumab
3
dehydroftorafur
3
avelumab
3
Transurethral Resection of Bladder
3
Radiotherapy
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Cystectomy
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
atezolizumab
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Carboplatin
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
tislelizumab
×
30 days
×
Clear all
No trials found.